Lipella Pharmaceuticals Inc. (NASDAQ: LIPO)
$0.46
-0.0041 ( -0.89% ) 11.0K
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
Market Data
Open
$0.46
Previous close
$0.46
Volume
11.0K
Market cap
$3.50M
Day range
$0.46 - $0.50
52 week range
$0.40 - $2.71
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 15, 2024 |
| 4 | Insider transactions | 1 | Mar 15, 2024 |
| 8-k | 8K-related | 16 | Mar 15, 2024 |
| 10-k | Annual reports | 77 | Feb 27, 2024 |
| 8-k | 8K-related | 12 | Dec 01, 2023 |
| 8-k | 8K-related | 12 | Nov 28, 2023 |
| 8-k | 8K-related | 12 | Nov 22, 2023 |
| 10-q | Quarterly Reports | 64 | Nov 14, 2023 |